{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:11:37Z","timestamp":1793391097286,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272543"],"award-info":[{"award-number":["82272543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.metabol.2025.156186","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:01:22Z","timestamp":1741708882000},"page":"156186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signaling"],"prefix":"10.1016","volume":"167","author":[{"given":"Chunmei","family":"Xiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuannan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangkai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156186_bb0005","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1039\/D3FO03830K","article-title":"Piperlongumine, a Piper longum-derived amide alkaloid, protects mice from ovariectomy-induced osteoporosis by inhibiting osteoclastogenesis via suppression of p38 and JNK signaling","volume":"15","author":"Luo","year":"2024","journal-title":"Food Funct"},{"key":"10.1016\/j.metabol.2025.156186_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175073","article-title":"HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice","volume":"927","author":"Sun","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156186_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155746","article-title":"Tm4sf19 deficiency inhibits osteoclast multinucleation and prevents bone loss","volume":"151","author":"Park","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156186_bb0020","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in Cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0025","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.7150\/thno.44793","article-title":"Genetic and pharmacological activation of hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK\/c-Fos-NFATc1 cascade","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2025.156186_bb0030","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jbmr.4328","article-title":"An antioxidant Sesquiterpene inhibits Osteoclastogenesis via blocking IPMK\/TRAF6 and counteracts OVX-induced osteoporosis in mice","volume":"36","author":"Wang","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI121561","article-title":"Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain","volume":"129","author":"Zhu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156186_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.metabol.2025.156186_bb0045","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1080\/15548627.2022.2048432","article-title":"TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss","volume":"18","author":"Yang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.metabol.2025.156186_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8515-6","article-title":"Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts","volume":"51","author":"Baum","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.metabol.2025.156186_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jare.2024.03.021","article-title":"Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction","volume":"69","author":"Zheng","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0060","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/bph.15024","article-title":"Overview of treatment approaches to osteoporosis","volume":"178","author":"Langdahl","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156186_bb0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2025.156186_bb0070","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological Management of Osteoporosis in postmenopausal women: An Endocrine Society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156186_bb0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156186_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jot.2023.06.002","article-title":"Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss","volume":"42","author":"Ma","year":"2023","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.metabol.2025.156186_bb0085","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00018-018-2817-9","article-title":"Mechanisms involved in normal and pathological osteoclastogenesis","volume":"75","author":"Park-Min","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2025.156186_bb0090","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s42255-020-00318-y","article-title":"Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution","volume":"2","author":"Tsukasaki","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2025.156186_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00281-019-00757-0","article-title":"Metabolic reprogramming in osteoclasts","volume":"41","author":"Park-Min","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.metabol.2025.156186_bb0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11914-023-00825-3","article-title":"Novel insights into osteoclast energy metabolism","volume":"21","author":"Ledesma-Colunga","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.metabol.2025.156186_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.997358","article-title":"Mitochondrial fatty acid beta-oxidation is important for normal osteoclast formation in growing female mice","volume":"13","author":"Kushwaha","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2025.156186_bb0110","doi-asserted-by":"crossref","first-page":"21020","DOI":"10.1038\/s41598-020-77892-4","article-title":"Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis","volume":"10","author":"Taubmann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156186_bb0115","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/jbmr.1976","article-title":"Metabolic regulation of osteoclast differentiation and function","volume":"28","author":"Indo","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.30802\/AALAS-CM-21-000012","article-title":"Relationships between Slc1a5 and Osteoclastogenesis","volume":"71","author":"Tsumura","year":"2021","journal-title":"Comp Med"},{"key":"10.1016\/j.metabol.2025.156186_bb0125","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1172\/JCI89935","article-title":"MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha","volume":"127","author":"Bae","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156186_bb0130","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.7150\/thno.99565","article-title":"Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2025.156186_bb0135","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1038\/s44319-024-00255-x","article-title":"Glutaminolysis provides nucleotides and amino acids to regulate osteoclast differentiation in mice","volume":"25","author":"Hu","year":"2024","journal-title":"EMBO Rep"},{"key":"10.1016\/j.metabol.2025.156186_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156147","article-title":"FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD(+) axis","volume":"165","author":"Chen","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156186_bb0145","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.7150\/ijbs.64046","article-title":"Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development","volume":"17","author":"Qu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.metabol.2025.156186_bb0150","first-page":"25","article-title":"Fatty Acid Synthase: An Emerging Target in Cancer","author":"Fhu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.metabol.2025.156186_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155660","article-title":"miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis","volume":"146","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156186_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155563","article-title":"MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies","volume":"144","author":"Nagarajan","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156186_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155740","article-title":"Gut-derived ammonia contributes to alcohol-related fatty liver development via facilitating ethanol metabolism and provoking ATF4-dependent de novo lipogenesis activation","volume":"151","author":"Song","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156186_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156186_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155589","article-title":"Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis","volume":"144","author":"Vazquez-Borrego","year":"2023","journal-title":"Metabolism"},{"issue":"866\u201380","key":"10.1016\/j.metabol.2025.156186_bb0180","article-title":"Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR Malonylation","volume":"28","author":"Bruning","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156186_bb0185","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.RA118.001921","article-title":"An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation","volume":"293","author":"Carroll","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156186_bb0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jbmr.2150","article-title":"Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it","volume":"29","author":"Drosatos-Tampakaki","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bone.2019.02.017","article-title":"Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice","volume":"122","author":"Bermeo","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2025.156186_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174176","article-title":"Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss","volume":"904","author":"Zhang","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2025.156186_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2025.156186_bb0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.metabol.2025.156186_bb0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2025.156186_bb0220","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.metabol.2025.156186_bb0225","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2025.156186_bb0230","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jbmr.4485","article-title":"Hedgehog signaling controls bone homeostasis by regulating osteogenic\/Adipogenic fate of skeletal stem\/progenitor cells in mice","volume":"37","author":"Zhang","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156186_bb0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2013.04.084","article-title":"AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis","volume":"435","author":"Li","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2025.156186_bb0240","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.intimp.2018.03.021","article-title":"Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-kappaB pathways","volume":"58","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.metabol.2025.156186_bb0245","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","article-title":"STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription","volume":"294","author":"Yang","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156186_bb0250","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/glia.24113","article-title":"DHHC5 facilitates oligodendrocyte development by palmitoylating and activating STAT3","volume":"70","author":"Ma","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.metabol.2025.156186_bb0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","article-title":"A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis","volume":"586","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2025.156186_bb0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41419-024-06456-5","article-title":"Dietary long-chain fatty acids promote colitis by regulating palmitoylation of STAT3 through CD36-mediated endocytosis","volume":"15","author":"Wei","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2025.156186_bb0265","doi-asserted-by":"crossref","first-page":"eadd2282","DOI":"10.1126\/scisignal.add2282","article-title":"STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice","volume":"16","author":"Jiang","year":"2023","journal-title":"Sci Signal"},{"key":"10.1016\/j.metabol.2025.156186_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12951-022-01413-w","article-title":"NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.metabol.2025.156186_bb0275","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1016\/j.apsb.2023.07.001","article-title":"Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS\/PPARgamma\/FABP4 signaling in mice","volume":"13","author":"Tang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.metabol.2025.156186_bb0280","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:37:02Z","timestamp":1743986222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":56,"alternative-id":["S0026049525000551"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156186","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signaling","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156186"}}